NICE Guidelines for Shock Management in Adults

For adult patients presenting with shock, immediately initiate fluid resuscitation with at least 30 mL/kg of intravenous crystalloid within the first 3 hours, start norepinephrine as the first-line vasopressor when mean arterial pressure remains below 65 mmHg after adequate fluid loading, and rapidly identify the underlying etiology to guide definitive treatment. 1, 2

Initial Recognition and Classification

Rapid Hemodynamic Assessment

Measure blood pressure, heart rate, respiratory rate, temperature, urine output, and mental status immediately to establish baseline hemodynamics and detect early signs of organ hypoperfusion. 2
Obtain serum lactate immediately at shock recognition; an elevated lactate (≥2 mmol/L) confirms tissue hypoperfusion and serves as a quantitative marker for resuscitation adequacy. 1, 2
Classify shock into four major categories based on clinical and hemodynamic findings: hypovolemic (intravascular volume loss), distributive (pathological vasodilation, most commonly septic), cardiogenic (primary cardiac dysfunction), or obstructive (mechanical blockage of circulation). 3, 4

Point-of-Care Ultrasound for Shock Classification

Perform bedside echocardiography to differentiate shock types by assessing cardiac contractility, chamber size, valvular function, and inferior vena cava collapsibility; this distinguishes cardiogenic shock (reduced ejection fraction, dilated ventricles) from distributive shock (hyperdynamic heart, small ventricles) and identifies obstructive causes (tamponade, massive pulmonary embolism). 5, 6

Immediate Resuscitation (First 3 Hours)

Fluid Resuscitation Strategy

Administer at least 30 mL/kg of isotonic crystalloid (normal saline or balanced solution) within the first 3 hours as rapid 500–1000 mL boluses over 5–10 minutes; for a 70 kg adult this equals approximately 2 liters. 1, 2
Continue additional 250–500 mL crystalloid boluses guided by dynamic indices (pulse-pressure variation, stroke-volume variation) or static variables (blood pressure, heart rate, urine output) while hemodynamic improvement persists. 1, 2
Avoid hydroxyethyl starch formulations because they increase acute kidney injury risk and mortality compared to crystalloids. 2

Monitoring for Fluid Overload

Assess for signs of fluid intolerance during ongoing resuscitation: elevated jugular venous pressure, rising respiratory rate, decreasing oxygen saturation, and pulmonary crackles; reduce or stop fluid infusion when these appear. 2

Hemodynamic Targets (First 6 Hours)

Blood Pressure Goals

Target mean arterial pressure (MAP) ≥65 mmHg in most adults; below this threshold organ autoregulation fails and perfusion becomes pressure-dependent. 1, 2
For patients with chronic hypertension, target MAP 70–85 mmHg because their autoregulatory curve is shifted rightward and lower pressures may result in inadequate organ perfusion. 1, 2

Perfusion Endpoints Beyond MAP

Maintain urine output ≥0.5 mL/kg/hour as a bedside marker of adequate renal perfusion. 1, 2
Target central venous pressure (CVP) 8–12 mmHg (or 12–15 mmHg if mechanically ventilated) to assess fluid responsiveness. 2
Achieve central venous oxygen saturation (ScvO₂) ≥70% (or mixed venous O₂ saturation ≥65%) to confirm sufficient tissue oxygen delivery. 2
Verify capillary refill time ≤2 seconds together with warm extremities, normal mental status, and palpable peripheral pulses as additional perfusion endpoints. 1, 2

Lactate Clearance Protocol

Repeat lactate measurement within 6 hours if the initial value is elevated; use lactate normalization as a dynamic resuscitation endpoint. 1, 2
Target lactate clearance of ≥10% every 2 hours during the first 8 hours of resuscitation as the primary therapeutic goal. 2

Vasopressor Management

First-Line Agent: Norepinephrine

Initiate norepinephrine as the mandatory first-line vasopressor when MAP remains <65 mmHg after the initial 30 mL/kg fluid bolus, starting at 0.05–0.1 µg/kg/min (≈5–10 µg/min for a 70 kg adult) and titrating to maintain MAP ≥65 mmHg. 1, 2
Norepinephrine is superior to dopamine with an 11% absolute mortality reduction, significantly fewer supraventricular arrhythmias (RR 0.47), and 65% fewer ventricular arrhythmias (RR 0.35). 1
Administer norepinephrine through central venous access whenever possible to minimize tissue necrosis risk from extravasation; peripheral administration is acceptable initially to avoid delays. 1, 2

Escalation Strategy for Refractory Hypotension

Add vasopressin at a fixed dose of 0.03 units/min when norepinephrine reaches 0.1–0.25 µg/kg/min and MAP remains <65 mmHg; vasopressin must always be combined with norepinephrine, never used as monotherapy. 1, 2
Do not exceed vasopressin doses of 0.03–0.04 units/min except as salvage therapy; higher doses cause cardiac, digital, and splanchnic ischemia without additional hemodynamic benefit. 1
Introduce epinephrine starting at 0.05 µg/kg/min (titrating up to 0.3 µg/kg/min) when MAP cannot be achieved with norepinephrine plus vasopressin. 1, 2

Agents to Avoid

Dopamine is strongly contraindicated as first-line therapy (Grade 1A recommendation); reserve only for highly selected patients with bradycardia and low arrhythmia risk. 1
Low-dose dopamine for renal protection is strongly discouraged (Grade 1A); it provides no benefit and delays appropriate therapy. 1
Phenylephrine is not recommended except in three specific scenarios: norepinephrine-induced serious arrhythmias, documented high cardiac output with persistent hypotension, or salvage therapy after failure of all other agents. 1

Inotropic Support for Persistent Hypoperfusion

When to Add Dobutamine

Add dobutamine 2.5–20 µg/kg/min when MAP is adequate (≥65 mmHg) but signs of tissue hypoperfusion persist (elevated lactate, low urine output, altered mental status, cold extremities), especially if myocardial dysfunction is evident on echocardiography. 1, 2
Dobutamine increases cardiac output through β₁-adrenergic stimulation while improving tissue perfusion in low-output states. 1

Etiology-Specific Management

Septic Shock

Administer broad-spectrum intravenous antibiotics within 1 hour of septic shock recognition; each hour of delay reduces survival by approximately 7.6%. 2
Obtain at least two sets of blood cultures (aerobic and anaerobic) before antibiotics, but never postpone antimicrobial administration beyond 45 minutes to obtain cultures. 2
Identify or exclude a specific anatomic infection source requiring emergent intervention (abscess, infected device, bowel perforation) within 12 hours of shock onset. 2
Perform definitive source-control procedures (drainage, debridement, removal of infected devices) as soon as medically and logistically feasible. 2

Cardiogenic Shock

Norepinephrine is the first-line vasopressor because its combined α-adrenergic vasoconstriction and modest β₁-adrenergic cardiac stimulation preserves or improves cardiac output. 7, 5
Titrate dobutamine to restore cardiac output when norepinephrine alone maintains MAP but organ perfusion remains inadequate. 7, 5
Perform urgent coronary angiography when acute myocardial ischemia is suspected, followed by culprit-vessel revascularization if indicated. 7, 5
Consider temporary mechanical circulatory support (intra-aortic balloon pump, ventricular assist device) if pharmacologic therapy fails to restore adequate perfusion. 7, 5

Hypovolemic Shock

Fluid replacement with balanced crystalloids is the primary treatment; continue boluses until hemodynamic improvement plateaus. 3, 4
Identify and control the source of volume loss (hemorrhage, gastrointestinal losses, burns) as definitive therapy. 3, 4

Obstructive Shock

Immediate life-saving intervention to relieve the obstruction is the definitive treatment (pericardiocentesis for tamponade, thrombolysis or embolectomy for massive pulmonary embolism, needle decompression for tension pneumothorax). 3, 4

Hemodynamic Monitoring

Arterial Catheter Placement

Place an arterial catheter for continuous blood-pressure monitoring as soon as practical after vasopressor initiation to allow precise MAP titration. 1, 2

Reassessment Frequency

Reassess hemodynamic status frequently using clinical examination (heart rate, blood pressure, respiratory rate, temperature, urine output, mental status) to detect early deterioration or improvement. 2
Monitor blood pressure and heart rate every 5–15 minutes during vasopressor titration. 2

Common Pitfalls and How to Avoid Them

Pitfall 1: Relying Solely on MAP

MAP alone does not guarantee adequate tissue perfusion; normal MAP can coexist with severe tissue hypoperfusion ("cold shock"). Always assess lactate clearance, urine output, mental status, and skin perfusion. 1, 2

Pitfall 2: Delaying Vasopressors for Excessive Fluid

Do not delay norepinephrine while pursuing aggressive fluid resuscitation in severe hypotension; early vasopressor use is appropriate when diastolic blood pressure is critically low. 1, 2

Pitfall 3: Using Dopamine as First-Line Therapy

Dopamine is associated with 11% higher absolute mortality and significantly more arrhythmias compared to norepinephrine; avoid its use except in highly selected patients. 1

Pitfall 4: Exceeding Vasopressin Dosing Limits

Vasopressin doses above 0.03–0.04 units/min cause end-organ ischemia without additional hemodynamic benefit; discontinuation at lower doses restores organ perfusion. 1

Pitfall 5: Fluid Overload in Established Shock

Excessive fluid administration after initial resuscitation prolongs life-threatening hypotension, risks pulmonary edema, and worsens outcomes; use dynamic indices to guide ongoing fluid therapy. 2

Adjunctive Therapies

Corticosteroids

Do not use routine intravenous hydrocortisone when adequate fluid resuscitation and vasopressor therapy have restored hemodynamic stability. 2, 8
Consider hydrocortisone 200 mg/day only if hemodynamic stability cannot be achieved despite adequate resuscitation (weak recommendation). 2, 8

Blood Product Management

Transfuse red blood cells only when hemoglobin <7 g/dL, targeting a range of 7–9 g/dL unless active myocardial ischemia, severe hypoxemia, or acute hemorrhage is present. 2, 8

Mechanical Ventilation (If Required)

Use lung-protective ventilation: tidal volume 6 mL/kg predicted body weight, plateau pressure ≤30 cm H₂O, and head-of-bed elevation 30–45°. 9, 8

What are the recommended guidelines for assessing and managing shock in an adult patient without known comorbidities?

Help us tailor your experience